Physician profile
Edward P Chen
NPI 1801985882
$12,789.65
in general payments reported to CMS, 2019-2025
12 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,301 · 2020: $224 · 2021: $68.46 · 2022: $2,148 · 2023: $1,671 · 2024: $253 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $1,495 · Food and Beverage: $554.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $1,494.51 |
| Food and Beverage | $554.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $7,956.01 | 2019 | |
| Medtronic, INC. | $3,501.86 | 2022-2023 | |
| Abbott Laboratories | $340.04 | 2019-2020 | |
| Abbvie INC. | $309.10 | 2023-2024 | Botox |
| Bolton Medical INC | $177.08 | 2019 | |
| Allergan, INC. | $174.73 | 2021-2022 | |
| Edwards Lifesciences Corporation | $120.57 | 2024 | |
| Pfizer INC. | $96.57 | 2025 | |
| Artivion, INC. | $51.64 | 2020 | |
| Janssen Biotech, INC. | $28.05 | 2025 | Tremfya |
| Baxter Healthcare | $18.47 | 2021 | |
| Ucb, INC. | $15.53 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.